Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2015, Article ID 610931, 6 pages
http://dx.doi.org/10.1155/2015/610931
Research Article

Frequency of Red Cell Alloimmunization and Autoimmunization in Thalassemia Patients: A Report from Eastern India

1Department of Transfusion Medicine, The Mission Hospital, Durgapur, West Bengal 713212, India
2Department of Transfusion Medicine, AIIMS, Bhubaneswar 751019, India
3Department of Immunohematology & Blood Transfusion, MCH, Kolkata 700073, India

Received 29 June 2015; Accepted 5 August 2015

Academic Editor: Thomas Kickler

Copyright © 2015 Suvro Sankha Datta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Shah, P. Chowdhary, and A. P. Dubey, “Current trends in management of beta thalassemia,” Indian Journal of Pediatrics, vol. 36, pp. 1229–1242, 1999. View at Google Scholar
  2. L.-Y. Wang, D.-C. Liang, H.-C. Liu et al., “Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan,” Transfusion Medicine, vol. 16, no. 3, pp. 200–203, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. K. S. Trudell, “Detection and identification of antibodies,” in Modern Blood Banking and Transfusion Practices, D. M. Harmening, Ed., pp. 242–263, FA Davis, Philadelphia, Pa, USA, 5th edition, 2005. View at Google Scholar
  4. S. Charache, “Problems in transfusion therapy,” The New England Journal of Medicine, vol. 322, no. 23, pp. 1666–1668, 1990. View at Publisher · View at Google Scholar · View at Scopus
  5. J. M. Higgins and S. R. Sloan, “Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders,” Blood, vol. 112, no. 6, pp. 2546–2553, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Sirchia, A. Zanella, A. Parravicini, F. Morelati, P. Rebulla, and G. Masera, “Red cell alloantibodies in thalassemia major: results of an Italian cooperative study,” Transfusion, vol. 25, no. 2, pp. 110–112, 1985. View at Publisher · View at Google Scholar · View at Scopus
  7. S. T. Singer, V. Wu, R. Mignacca, F. A. Kuypers, P. Morel, and E. P. Vichinsky, “Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent,” Blood, vol. 96, no. 10, pp. 3369–3373, 2000. View at Google Scholar · View at Scopus
  8. S. Pahuja, M. Pujani, S. K. Gupta, J. Chandra, and M. Jain, “Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin,” Hematology, vol. 15, no. 3, pp. 174–177, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Kruatrachue, S. Sirisinha, P. Pacharee, D. Chandarayingyong, and P. Wasi, “An association between thalassaemia and autoimmune haemolytic anaemia (AIHA),” Scandinavian Journal of Haematology, vol. 25, no. 3, pp. 259–263, 1980. View at Google Scholar · View at Scopus
  10. F. Argiolu, G. Diana, M. Arnone, M. G. Batzella, P. Piras, and A. Cao, “High-dose intravenous immunoglobulin in the management of autoimmune hemolytic anemia complicating thalassemia major,” Acta Haematologica, vol. 83, no. 2, pp. 65–68, 1990. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Meny, “Review: transfusing incompatible RBCs-clinical aspects,” Immunohematology, vol. 20, no. 3, pp. 161–166, 2004. View at Google Scholar
  12. D. Mukhopadhyay, K. Saha, M. Sengupta, S. Mitra, C. Datta, and P. K. Mitra, “Spectrum of hemoglobinopathies in West Bengal, India: a CE-HPLC Study on 10407 subjects,” Indian Journal of Hematology and Blood Transfusion, vol. 31, no. 1, pp. 98–103, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. S. M. Coles, H. G. Klein, and P. V. Holland, “Alloimmunization in two multitransfused patient populations,” Transfusion, vol. 21, no. 4, pp. 462–466, 1981. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Economidou, M. Constantoulakis, O. Augoustaki, and M. Adinolfi, “Frequency of antibodies to various antigenic determinants in polytransfused patients with homozygous thalassaemia in Greece,” Vox Sanguinis, vol. 20, no. 3, pp. 252–258, 1971. View at Publisher · View at Google Scholar · View at Scopus
  15. A. G. M. A. Gader, A. K. Al Ghumlas, and A. K. M. Al-Momen, “Transfusion medicine in a developing country—alloantibodies to red blood cells in multi-transfused patients in Saudi Arabia,” Transfusion and Apheresis Science, vol. 39, no. 3, pp. 199–204, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. C. K. Cheng, C. K. Lee, and C. K. Lin, “Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review,” Transfusion, vol. 52, no. 10, pp. 2220–2224, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. A. M. Ahmed, N. S. Hasan, S. H. Ragab, S. A. Habib, N. A. Emara, and A. A. Aly, “Red cell alloimmunization and autoantibodies in Egyptian transfusion-dependent thalassaemia patients,” Archives of Medical Science, vol. 6, no. 4, pp. 592–598, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Guirat-Dhouib, M. Mezri, H. Hmida et al., “High frequency of autoimmunization among transfusion-dependent Tunisian thalassaemia patients,” Transfusion and Apheresis Science, vol. 45, no. 2, pp. 199–202, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Thakral, K. Saluja, R. R. Sharma, and N. Marwaha, “Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India,” Hematology, vol. 13, no. 5, pp. 313–318, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Sood, R. N. Makroo, V. Riana, and N. L. Rosamma, “Detection of alloimmunization to ensure safer transfusion practice,” Asian Journal of Transfusion Science, vol. 7, no. 2, pp. 135–139, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. H. K. Dhawan, V. Kumawat, N. Marwaha et al., “Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: study on 319 patients,” Asian Journal of Transfusion Science, vol. 8, no. 2, pp. 84–88, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Dogra, M. Sidhu, R. Kapoor, and D. Kumar, “Study of red blood cell alloimmunization in multitransfused thalassemic children of Jammu region,” Asian Journal of Transfusion Science, vol. 9, no. 1, p. 78, 2015. View at Publisher · View at Google Scholar
  23. C. A. Tormey, J. Fisk, and G. Stack, “Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans,” Transfusion, vol. 48, no. 10, pp. 2069–2076, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. W. F. Rosse, D. Gallagher, T. R. Kinney et al., “Transfusion and alloimmunization in sickle cell disease. The cooperative study of sickle cell disease,” Blood, vol. 76, no. 7, pp. 1431–1437, 1990. View at Google Scholar · View at Scopus
  25. J. Poole and G. Daniels, “Blood group antibodies and their significance in transfusion medicine,” Transfusion Medicine Reviews, vol. 21, no. 1, pp. 58–71, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. A. S. El Danasoury, D. G. Eissa, R. M. Abdo, and M. S. Elalfy, “Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program,” Transfusion, vol. 52, no. 1, pp. 43–47, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. J. E. Hendrickson, M. Desmarets, S. S. Deshpande et al., “Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells,” Transfusion, vol. 46, no. 9, pp. 1526–1536, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. E. G. Reisner, D. D. Kostyu, G. Phillips, C. Walker, and D. V. Dawson, “Alloantibody responses in multiply transfused sickle cell patients,” Tissue Antigens, vol. 30, no. 4, pp. 161–166, 1987. View at Google Scholar · View at Scopus
  29. D. A. Saied, A. M. Kaddah, R. M. Badr Eldin, and S. S. Mohaseb, “Alloimmunization and erythrocyte autoimmunization in transfusion-dependent Egyptian thalassemic patients,” Journal of Pediatric Hematology/Oncology, vol. 33, no. 6, pp. 409–414, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Yousuf, S. Abdul Aziz, N. Yusof, and C. F. Leong, “Incidence of red cell alloantibody among the transfusion recipients of Universiti Kebangsaan Malaysia medical centre,” Indian Journal of Hematology and Blood Transfusion, vol. 29, no. 2, pp. 65–70, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Guastafierro, F. Sessa, C. Cuomo, and A. Tirelli, “Delayed hemolytic transfusion reaction due to anti-S antibody in patient with anti-Jka autoantibody and multiple alloantibodies,” Annals of Hematology, vol. 83, no. 5, pp. 307–308, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. M. N. Haslina, N. Ariffin, I. I. Hayati, and H. Roseline, “Red cell alloimmunization in multiply transfused malay thalassemic patients,” The Southeast Asian Journal of Tropical Medicine and Public Health, vol. 37, pp. 1015–1020, 2006. View at Google Scholar
  33. R. Ameen, O. Al-Eyaadi, S. Al-Shemmari, R. Chowdhury, and A. Al-Bashir, “Frequency of red blood cell alloantibody in Kuwaiti population,” Medical Principles and Practice, vol. 14, no. 4, pp. 230–234, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Aygun, S. Padmanabhan, C. Paley, and V. Chandrasekaran, “Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions,” Transfusion, vol. 42, no. 1, pp. 37–43, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. S. M. Castellino, M. R. Combs, S. A. Zimmerman, P. D. Issitt, and R. E. Ware, “Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance,” British Journal of Haematology, vol. 104, no. 1, pp. 189–194, 1999. View at Publisher · View at Google Scholar · View at Scopus